Abstract
Intrapleurally injected cells of an ascitic rat tumour produced intrapleural effusions and solid pleural deposits. BCG, or its methanol extraction residue (MER) injected into the pleural space, suppressed tumour development and prolonged survival. Treatment was effective if given a few days before or after tumour injection. In contrast, active specific immunotherapy by repeated s.c. injection of viable or radiation-attenuated tumour cells in admixture with BCG was unsuccessful, and did not improve the response to intrapleural BCG treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Pimm, M., Hopper, D. & Baldwin, R. BCG treatment of malignant pleural effusions in the rat. Br J Cancer 34, 368–373 (1976). https://doi.org/10.1038/bjc.1976.179
Issue Date:
DOI: https://doi.org/10.1038/bjc.1976.179
This article is cited by
-
Histopathology of BCG and thiotepa treated bladders
Urological Research (1986)
-
Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting
CANCER AND METASTASIS REVIEW (1983)
